LIST OF TABLES
TABLE 01.PAIN MANAGEMENT DRUGS MARKET, BY DRUG CLASS, 2019-2027 ($MILLION)
TABLE 02.PAIN MANAGEMENT DRUGS MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 03.PAIN MANAGEMENT DRUGS MARKET, BY PAIN TYPE, 2019-2027 ($MILLION)
TABLE 04.GULF PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 05.UAE GULF PAIN MANAGEMENT DRUGS MARKET, BY DRUG CLASS, 2019-2027 ($MILLION)
TABLE 06.UAE GULF PAIN MANAGEMENT DRUGS MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 07.UAE GULF PAIN MANAGEMENT DRUGS MARKET, BY PAIN TYPE, 2019-2027 ($MILLION)
TABLE 08.SAUDI ARABIA GULF PAIN MANAGEMENT DRUGS MARKET, BY DRUG CLASS, 2019-2027 ($MILLION)
TABLE 09.SAUDI ARABIA GULF PAIN MANAGEMENT DRUGS MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 10.SAUDI ARABIA GULF PAIN MANAGEMENT DRUGS MARKET, BY PAIN TYPE, 2019-2027 ($MILLION)
TABLE 11.OMAN GULF PAIN MANAGEMENT DRUGS MARKET, BY DRUG CLASS, 2019-2027 ($MILLION)
TABLE 12.OMAN GULF PAIN MANAGEMENT DRUGS MARKET, BY INDICATION, 2019-2027 ($MILLION)
TABLE 13.OMAN GULF PAIN MANAGEMENT DRUGS MARKET, BY PAIN TYPE, 2019-2027 ($MILLION)
TABLE 14.GULF PAIN MANAGEMENT DRUGS MARKET FOR OTHERS, BY DRUG CLASS, 2019-2027 ($MILLION)
TABLE 15.GULF PAIN MANAGEMENT DRUGS MARKET FOR OTHERS, BY INDICATION, 2019-2027 ($MILLION)
TABLE 16.GULF PAIN MANAGEMENT DRUGS MARKET FOR OTHERS, BY PAIN TYPE, 2019-2027 ($MILLION)
TABLE 17.ABBOTT: COMPANY SNAPSHOT
TABLE 18.ABBOTT: OERATING SEGMENT
TABLE 19.ABBOTT: PRODUCT PORTFOLIO
TABLE 20.ELI LILLY: COMPANY SNAPSHOT
TABLE 21.LILLY: OPERATING SEGMENTS
TABLE 22.ELI LILLY: PRODUCT PORTFOLIO
TABLE 23.ELI LILLY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 24.GSK: COMPANY SNAPSHOT
TABLE 25.GSK: OPERATING SEGMENTS
TABLE 26.GSK: PRODUCT PORTFOLIO
TABLE 27.J&J: COMPANY SNAPSHOT
TABLE 28.J&J: OPERATING BUSINESS SEGMENTS
TABLE 29.J&J: PRODUCT PORTFOLIO
TABLE 30.MERCK & CO., INC.: COMPANY SNAPSHOT
TABLE 31.MERCK & CO., INC.: OPERATING SEGMENTS
TABLE 32.MERCK & CO., INC.: PRODUCT PORTFOLIO
TABLE 33.MERCK & CO., INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 34.MYLAN: COMPANY SNAPSHOT
TABLE 35.MYLAN: OPERATING BUSINESS SEGMENTS
TABLE 36.MYLAN: PRODUCT PORTFOLIO
TABLE 37.NOVARTIS: COMPANY SNAPSHOT
TABLE 38.NOVARTIS: OPERATING SEGMENTS
TABLE 39.NOVARTIS: PRODUCT PORTFOLIO
TABLE 40.PFIZER: COMPANY SNAPSHOT
TABLE 41.PFIZER: OERATING SEGMENT
TABLE 42.PFIZER: PRODUCT PORTFOLIO
TABLE 43.JULPHAR: COMPANY SNAPSHOT
TABLE 44.JULPHAR: PRODUCT PORTFOLIO
TABLE 45.JULPHAR: COMPANY SNAPSHOT
TABLE 46.JULPHAR: PRODUCT PORTFOLIO
LIST OF FIGURE
LIST OF FIGURES
FIGURE 01.PAIN MANAGEMENT DRUGS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, 2017-2020
FIGURE 04.TOP WINNING STRATEGIES: NATURE AND TYPE, 2017-2020
FIGURE 05.TOP WINNING STRATEGIES: BY YEAR, 2017-2020
FIGURE 06.TOP PLAYER POSTIONING, 2019
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 09.MODERATE THREAT OF SUBSTITUTES
FIGURE 10.MODEARTE THREAT OF NEW ENTRANTS
FIGURE 11.MODERATE COMPETITIVE OF RIVALRY
FIGURE 12.IMPACT ANALYSIS, GULF PAIN MANAGEMENT DRUGS MARKET
FIGURE 13.GULF PAIN MANAGEMENT DRUGS MARKET, FOR NSAIDS, 2019-2027 ($MILLION)
FIGURE 14.GULF PAIN MANAGEMENT DRUGS MARKET, FOR ANAESTHETIC, 2019-2027 ($MILLION)
FIGURE 15.GULF PAIN MANAGEMENT DRUGS MARKET, FOR ANTICONVULSANTS, 2019-2027 ($MILLION)
FIGURE 16.GULF PAIN MANAGEMENT DRUGS MARKET, FOR ANTI-MIGRAINE AGENTS, 2019-2027 ($MILLION)
FIGURE 17.GULF PAIN MANAGEMENT DRUGS MARKET, FOR ANTIDEPRESSANTS, 2019-2027 ($MILLION)
FIGURE 18.GULF PAIN MANAGEMENT DRUGS MARKET, FOR OPIOIDS, 2019-2027 ($MILLION)
FIGURE 19.GULF PAIN MANAGEMENT DRUGS MARKET, FOR NON-NARCOTIC ANALGESICS, 2019-2027 ($MILLION)
FIGURE 20.GULF PAIN MANAGEMENT DRUGS MARKET, FOR ARTHRITIC PAIN BY, 2019-2027 ($MILLION)
FIGURE 21.GULF PAIN MANAGEMENT DRUGS MARKET, FOR NEUROPATHIC PAIN, 2019-2027 ($MILLION)
FIGURE 22.GULF PAIN MANAGEMENT DRUGS MARKET, FOR CANCER PAIN, 2019-2027 ($MILLION)
FIGURE 23.GULF PAIN MANAGEMENT DRUGS MARKET, FOR CHRONIC BACK PAIN, 2019-2027 ($MILLION)
FIGURE 24.GULF PAIN MANAGEMENT DRUGS MARKET, FOR POST-OPERATIVE PAIN, 2019-2027 ($MILLION)
FIGURE 25.GULF PAIN MANAGEMENT DRUGS MARKET, FOR MIGRAINE, 2019-2027 ($MILLION)
FIGURE 26.GULF PAIN MANAGEMENT DRUGS MARKET, FOR FIBROMYALGIA, 2019-2027 ($MILLION)
FIGURE 27.GULF PAIN MANAGEMENT DRUGS MARKET, FOR BONE FRACTURE, 2019-2027 ($MILLION)
FIGURE 28.GULF PAIN MANAGEMENT DRUGS MARKET, FOR MUSCLE STRAIN/SPRAIN, 2019-2027 ($MILLION)
FIGURE 29.GULF PAIN MANAGEMENT DRUGS MARKET, FOR ACUTE APPENDICITIS, 2019-2027 ($MILLION)
FIGURE 30.GULF PAIN MANAGEMENT DRUGS MARKET, FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 31.GULF PAIN MANAGEMENT DRUGS MARKET, FOR CHRONIC PAIN, 2019-2027 ($MILLION)
FIGURE 32.GULF PAIN MANAGEMENT DRUGS MARKET, FOR ACUTE PAIN, 2019-2027 ($MILLION)
FIGURE 33.ABBOTT: NET SALES, 2017-2019 ($MILLION)
FIGURE 34.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.ELI LILLY: NET SALES, 2017-2019 ($MILLION)
FIGURE 37.ELI LILLY: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.GSK: NET SALES, 2017-2019 ($MILLION)
FIGURE 39.GSK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 40.GSK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 41.J&J: NET SALES, 2017-2019 ($MILLION)
FIGURE 42.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 43.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.MERCK & CO., INC.: NET SALES, 2017-2019 ($MILLION)
FIGURE 45.MERCK & CO., INC.: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.MERCK & CO., INC.: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 47.MYLAN: NET SALES, 2017-2019 ($MILLION)
FIGURE 48.MYLAN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 49.NOVARTIS: NET SALES, 2017-2019 ($MILLION)
FIGURE 50.NOVARTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 51.NOVARTIS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 52.PFIZER: NET SALES, 2017-2019 ($MILLION)
FIGURE 53.PFIZER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 54.PFIZER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 55.JULPHAR: NET SALES, 2015-2017 ($MILLION)
